Average Co-Inventor Count = 3.83
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Theravance, Inc. (38 from 386 patents)
2. Theravance Biopharma R&d Ip, LLC (35 from 262 patents)
73 patents:
1. 12384761 - Imidazolo indazole compounds as JAK inhibitors
2. 12172994 - Pyrimidine compound as JAK kinase inhibitor
3. 11697648 - Fused pyrimidine pyridinone compounds as JAK inhibitors
4. 11420965 - Pyrimidine compound as JAK kinase inhibitor
5. 11339160 - Imidazole and triazole containing bicyclic compounds as JAK inhibitors
6. 11254655 - Benzimidazole-carboxamide compounds as 5-HTreceptor agonists
7. 11160810 - Fused imidazo-piperidine JAK inhibitor compound
8. 10988470 - Pyrimidine compound as JAK kinase inhibitor
9. 10968205 - Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
10. 10851102 - Imidazole and triazole containing bicyclic compounds as JAK inhibitors
11. 10696656 - Benzimidazole-carboxamide compounds as 5-HTreceptor agonists
12. 10562894 - Pyrimidine compound as JAK kinase inhibitor
13. 10538513 - Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
14. 10392368 - Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
15. 10308646 - Pyrimidine compound as JAK kinase inhibitor